Today in the Humira® case, Fujifilm Kyowa Biologics Co., Ltd. v. Abbvie Biotechnology Limited, [2016]  EWHC 374(IP)(Ch)(High Court 2016)(Carr, J.), the trial court issued an opinion involving parallel proceedings within Europe relating to validity issues in a “must read” case worth studying by comparative law experts.
This writer will provide comments in due course.

A copy of the opinion is attached.